|
The Core Group provides leadership and sets the strategic direction for the work of the New Diagnostics Working Group. The Core Group is designed to facilitate and accelerate decision-making, and to act as a catalyst to effective implementation of the Global Plan to Stop TB. The Core Group is representative of the broad constituencies concerned with the development and implementation of new TB diagnostics and consists of the following members:
| Academia | Arend Kolk, University of Amsterdam, Netherlands |
| Diagnostic developer | Mark Perkins, FIND, Geneva, Switzerland |
| Diagnostic manufacturer | Jean-Francois de Lavison, EDMA, Belgium |
| Nongovernmental organization | Francis Varaine, MSF, Paris, France |
| Patient community | Savita Luka, New Delhi, India Mayowa Joel, Lagos, Nigeria |
| WHO Stop TB Partnership | Christian Lienhardt, Stop TB Partnership, Geneva, Switzerland |
| The Union | Anne Detjen, TREAT TB team, New York, USA |
| Global Laboratory Initiative | John Ridderhof, CDC, Atlanta, USA |
| National TB program manager | Charles Sandy, NTP, Zimbabwe |
|